Fulcrum Therapeutics to Host First Quarter 2023 Financial Re

Fulcrum Therapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Monday, May 15, 2023, at 8:00 a.m. ET

CAMBRIDGE, Mass., May 08, 2023 -- Fulcrum Therapeutics, Inc.® , a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases,... | May 8, 2023

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Chris Calabrese , Dee Smith , Linkedin , Drug Administration , Corporate Communications , Lifesci Advisors , Fulcrum Therapeutics Inc , Company Nasdaq , Twitter , Investor Relations , Sci Advisors , Fulcrum Therapeutics , Nc Stock Exchange , News , Information , Press Release , Bay , 023 , Fulcrum , Iopharmaceutical , Company , Ocused , N , Improving , The , Lives , F , Patients , Ith , Genetically , Efined , Are Fulc Us3596161097 ,